Is Xylazine legal in Switzerland?
- Legal status
- Xylazine is authorised in Switzerland as a prescription veterinary medicine regulated by Swissmedic under the Heilmittelgesetz (therapeutic-products law); it is a veterinary sedative and is not listed in the Betäubungsmittelverzeichnis of the Narcotics Act.
- Consequences if caught
- Supply of xylazine outside the veterinary channel breaches therapeutic-products law rather than the Narcotics Act, as it is not a controlled human drug.
- If prescribed or medical
- Dispensed on a veterinary prescription (Abgabekategorie B) for sedation/analgesia in animals; Swissmedic issues professional communications on xylazine-containing veterinary medicines, and no human authorisation exists.
- Documentation
- Xylazine-containing veterinary medicines are Swissmedic-authorised products and the subject of a Swissmedic healthcare-professional communication (HPC).
Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Switzerland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulate in the destination immediately — not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →